Product Information
BUSPIRONE HCL 15 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0423 per EA under NDC 59651039205. Its NADAC has been published 261 times since Aug 25, 2021.
FDA first approved this application on Feb 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651039205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078246FDA Approved
2/27/2009
TE Code
AB
On Market Since
2/21/2020
Price Statistics
The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 261 times since Aug 25, 2021, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0560 (Apr 13, 2022) |
| All-time low | $0.0359 (Nov 20, 2024) |
| 52-week high | $0.0485 |
| 52-week low | $0.0423 |
| Median price | $0.0481 |
| Average price | $0.0478 |
| Largest weekly change | -29.4% (Nov 20, 2024) |
| Weeks tracked | 261 |
| Tracking since | Aug 25, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0423 per EA (NDC 59651039205), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has declined 22.7%. It has been tracked across 261 weekly CMS publications since Aug 25, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?
Since Aug 25, 2021, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.0560 (Apr 13, 2022), with a median of $0.0481 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 15 MG TABLET?
BUSPIRONE HCL 15 MG TABLET (NDC 59651039205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.